Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Commercial
Patent
Patent
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Patent
Novartis withdraws patent claim on leukaemia treatment ...
Firstwordpharma News
-
December 16, 2019
Patent
Novartis withdraws patent claim on leukaemia treatment ...
Patent
Inventor Of “LessDrops,” Surgical Eyedrop, Wins Return Of Patent From Harrow Health
Patent
Tonix Pharmaceuticals Announces New European Patent for the Composition and Formulation of TNX-102 SL
Patent
Inventor Of “LessDrops,” Surgical Eyedrop, Wins Return Of Patent From Harrow Health
Patent
Tonix Pharmaceuticals Announces New European Patent for the Composition and...
Biospace News
-
December 11, 2019
0
Patent
Promore Pharma is granted a patent for PXL01 in the US
Biospace News
-
November 12, 2019
0
Patent
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast)...
Biospace News
-
October 28, 2019
0
Patent
Soligenix Receives US Patent for Improved Production of Synthetic Hypericin Composition
Biospace News
-
October 24, 2019
0
Patent
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for...
Biospace News
-
October 23, 2019
0
1
2
3
...
6
Page 1 of 6
- Advertisement -
MOST POPULAR
Ultragenyx to Host Conference Call for First Quarter 2019 Financial Results...
April 30, 2019
ASLAN, Aduro Initiate Corporate Restructuring That Includes Significant Layoffs
January 30, 2019
Pfizer gains FDA approval of Zirabev as a biosimilar of Roche’s...
June 28, 2019
BioSpace’s Global Biopharma Roundup: May 2
May 2, 2019
Load more
HOT NEWS
Commercial
Sutro Biopharma to Present at the Cowen and Company 39th Annual...
Others
New Data Presented at 24th EHA Congress From Oncopeptides’ Phase 1/2...
Genitourinary
Akebia Therapeutics Announces Positive Top-Line Results from Two Pivotal Phase 3...
Deals
Boehringer Ingelheim partners with Enleofen to develop anti-IL-11 therapies for fibrotic...
